Clinical Trial Update: A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the Embrace seizure detection watch in children and young adults with Dravet syndrome was terminated; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• Embrace seizure detection watch

Snippet

Sponsor: Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | Conditions: Dravet Syndrome | Phase 3 | Status: TERMINATED | Results posted: 2023-11-13